Supratrochlear Artery Thrombosis After Mohs Micrographic Surgery: Managing Anticoagulation in the Persistently Bleeding Patient

Main Article Content

Timothy Jay Orlowski
Carlton Phillips

Keywords

Anticoagulation, Bleeding, Mohs surgery, Dermatology

References

1. Chang TW, Arpey CJ, Baum CL, Brewer JD, et al. Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery. Dermatol Surg 2015;41:784-93.

2. Shaw JR, Kaplovitch E, Douketis J. Periprocedural Management of Oral Anticoagulation. Med Clin North Am 2020;104:709-26.

3. Iyengar S, Yeager DG, Cohen JL, Ozog DM. Update and Review of Bleeding Considerations in Dermatologic Surgery: Anticoagulants and Antiplatelets. Dermatol Surg 2020;46:192-201.

4. Erickson SP, Schneider SL, Cohen JL, Alam M, et al. Perioperative Practices in Dermatologic Surgery. Dermatol Surg 2022;48:924-26.

5. Bordeaux JS, Martires KJ, Goldberg D, Pattee SF, et al. Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications. J Am Acad Dermatol 2011;65:576-83.

Article Sidebar

PDF
Published
Sep 15, 2023
DOI https://doi.org/10.25251/skin.7.5.16

Article Details

How to Cite
Orlowski, T. J., & Phillips, C. (2023). Supratrochlear Artery Thrombosis After Mohs Micrographic Surgery: Managing Anticoagulation in the Persistently Bleeding Patient. SKIN The Journal of Cutaneous Medicine, 7(5), 1050–1052. https://doi.org/10.25251/skin.7.5.16
Issue
Vol. 7 No. 5 (2023): September 2023 Issue
Section
Short Communications
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.